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The wild-type A75/17 canine distemper virus (CDV) strain induces a persistent infection in the central nervous system but infects cell
lines very inefficiently. In contrast, the genetically more distant Onderstepoort CDV vaccine strain (OP-CDV) induces extensive syncytia
formation. Here, we investigated the roles of wild-type fusion (FWT) and attachment (HWT) proteins in Vero cells expressing, or not, the
canine SLAM receptor by transfection experiments and by studying recombinants viruses expressing different combinations of wild-type and
OP-CDV glycoproteins. We show that low fusogenicity is not due to a defect of the envelope proteins to reach the cell surface and that HWT
determines persistent infection in a receptor-dependent manner, emphasizing the role of SLAM as a potent enhancer of fusogenicity.
However, importantly, FWT reduced cell-to-cell fusion independently of the cell surface receptor, thus demonstrating that the fusion protein of
the neurovirulent A75/17-CDV strain plays a key role in determining persistent infection.
D 2005 Elsevier Inc. All rights reserved.Keywords: Canine distemper virus; Persistence; Fusogenicity; Envelope glycoproteins; SLAMIntroduction
Canine distemper virus (CDV) is a Morbillivirus closely
related to measles virus and depending on the viral strain
may cause encephalomyelitis in dogs. The wild-type
virulent A75/17-CDV strain typically produces a chronic
demyelinating disease associated with a persistent infection
in the central nervous system (CNS) (Bollo et al., 1986;
Higgins et al., 1989; Imagawa et al., 1980; Vandevelde et
al., 1980). The antiviral immune response, which follows
invasion of immune cells in the CNS, leads to viral
clearance within the inflammatory lesions (Bollo et al.,0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.04.012
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Lausanne, Lausanne, Switzerland.1986). However, this viral clearance is restricted to certain
lesions, and simultaneously, A75/17-CDV has been shown
to further spread in astrocytes in other areas of the brain
without eliciting an inflammatory response. Thus, A75/17-
CDV persistent infection in the CNS was suggested to be in
part determined by a defective immune response (Bollo et
al., 1986; Johnson et al., 1988; Vandevelde et al., 1986).
However, in primary dog brain cell culture, wild-type CDV
persistence was also associated with selective spread and
very little virus release when compared to the Onderstepoort
(OP) CDV vaccine strain (Zurbriggen et al., 1995),
suggesting an important role also for viral factors in the
establishment of persistent infection.
A75/17-V is a Vero cell-adapted CDV strain producing a
persistent infection characterized by a very limited cyto-
pathic effect (CPE). The virus spreads in a cell-to-cell
manner without obvious syncytium formation (Hamburger
et al., 1991; Meertens et al., 2003; Plattet et al., 2004). In
contrast, the Onderstepoort (OP) CDV vaccine strain, which05) 312 – 326
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pronounced CPE in many cell types accompanied by the
formation of large syncitia (Appel and Gillspie, 1972; Haig,
1956; Rockborn, 1959). Therefore, the non-cytolytic A75/
17-V strain represents a promising tool to study the genetic
determinants underlying viral persistence.
Both cell culture-adapted A75/17-V and OP-CDV have
very similar genome organization as compared to the A75/
17 wild-type strain and consists of a single-stranded
negative-sense RNA of 15690 nucleotides. While A75/
17-V differs from the wild-type strain by only seven amino
acids located in the P, V, M and L proteins (Plattet et al.,
2004), OP-CDV is genetically more distant and presents
about 9% amino acid differences.
The CDV envelope contains the attachment (H) and the
fusion (F) glycoproteins. The H protein binds to the CDV
receptor of the host cell membrane, and the F protein
mediates the membrane fusion event, which allows the entry
of the viral genome into the cytoplasm. The OP-CDV
cytolytic strain was demonstrated to spread through cell
cultures both by producing infectious extracellular particles
and by lateral cell-to-cell fusion (Gassen et al., 2000;
Schmid et al., 2000; von Messling et al., 2001; Zurbriggen
et al., 1995). Interestingly, it was shown that the coex-
pression of the F and H glycoproteins was necessary and
sufficient to induce cell fusion, and that the CDV H protein
was the major factor determining cell tropism (Stern et al.,
1995). In addition, reverse genetics technology based on the
OP-CDV strain suggested that not only the CDV tropism,
but also the cytopathogenicity, also termed fusogenicity, in
Vero cells were mainly determined by the H protein (von
Messling et al., 2001).
The observation that Vero cell adaptation of wild-type
CDV does not necessarily require amino acid changes in
the H protein (Nielsen et al., 2003; Plattet et al., 2004) is
inconsistent with the idea that host cell specificity is
determined exclusively by the H protein. Thus, the
question remains as to whether the phenotype of infection
observed with A75/17-V is mainly determined by the H
protein, as described for OP-CDV (von Messling et al.,
2001).
Fusogenicity was previously suggested to be mediated
both by viral factors and by cell surface receptors (Takeuchi
et al., 2002). The CDV receptor in Vero cells has not yet
been identified, although the CD9 molecule was shown to
influence CDV-induced cell-to-cell fusion, but not virus–
cell fusion (Loffler et al., 1997; Schmid et al., 2000). In
contrast, the expression of signaling lymphocytic activation
molecule (SLAM; also known as CD150) in non-susceptible
cell lines was reported to allow binding and entry of both
wild-type and vaccine CDV strains (Seki et al., 2003; Tatsuo
et al., 2001). In humans, SLAM expression is restricted to
activated T and B lymphocytes, immature thymocytes
(Cocks et al., 1995; Sidorenko and Clark, 1993) and mature
dendritic cells (Ohgimoto et al., 2001). The SLAM cDNA
of the dog has recently been isolated (Tatsuo et al., 2001)but the tissue distribution of SLAM in this species has not
yet been determined.
In this study, genetic determinants of the persistent
infection phenotype of A75/17-V, which exhibits identical F
and H proteins compared to the wild-type strain, were
characterized. Towards this end, the F and H proteins from
wild-type and OP-CDV were analyzed with respect to their
cell-to-cell fusion-inducing ability using a transient-expres-
sion system and a newly established A75/17-V-based
reverse genetics technology (Plattet et al., 2004). The role
of SLAM in fusogenicity was also evaluated. Our results
showed that both the wild-type F and H proteins as well as
the canine SLAM receptor act in concert to determine the
phenotype of infection.Results
Differences in fusogenicity between A75/17-V-CDV and
OP-CDV
Vero and Vero-dogSLAMtag cells were infected with the
two different CDV strains at an MOI of 0.001 and their
respective CPE-inducing ability was examined 24 h after
infection by phase contrast microscopy and immunofluor-
escence. Although no CPE was observed in Vero cells
infected with A75/17-V (Fig. 1A), immunofluorescence
analysis showed single cell staining of A75/17-V throughout
the cell monolayer (Fig. 1E). In these cells, OP-CDV
produced the expected pronounced level of CPE (Fig. 1B),
which was also confirmed by immunofluorescence analysis
(Fig. 1F).
In the presence of the canine SLAM receptor, the level of
CPE of OP-CDV was even more pronounced than in
SLAM-negative Vero cells (Figs. 1D, H). In contrast, A75/
17-V produced only few and small syncytia (Figs. 1C, G).
These results demonstrate that viral proteins are the major
determinants of cell-to-cell fusion but that SLAM also acts
as a fusion-enhancing molecule. Since both morbillivirus
envelope glycoproteins have been described as important
fusion modulators, we wished to dissect the role of the A75/
17-V F and H proteins in determining the low CPE-inducing
phenotype of infection.
Both viral surface glycoproteins and SLAM modulate
cell-to-cell fusion
As wild-type A75/17 and A75/17-V present identical F
and H proteins (Plattet et al., 2004), they were named in
this study wild-type F (FWT) and wild-type H (HWT). In
order to investigate the role of the two surface glycopro-
teins of OP-CDV and A75/17-V CDV in producing a
cytolytic versus persistent infection, we first carried out a
comparative analysis of the predicted amino acid sequences
between FWT and FOP as well as of HWT and HOP. The
sequence of FWT has already been published (Cherpillod et
Fig. 1. Difference in cell-to-cell fusion between A75/17-V CDV and OP-CDV. Vero and Vero-dogSLAMtag cells were infected with A75/17-V CDV and OP-
CDV at a MOI of 0.001 and observed after 24 h of infection by phase contrast microscopy (A-D). Representative fields of view are shown. Cells were also
stained with an anti-CDV N protein MAb, followed by FITC-conjugated-labeled anti-mouse IgG and observed under a fluorescence microscope (E–H).
Representative fields of view are shown.
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published sequence (Cherpillod et al., 1999) by 4 amino
acids has been deposited in GenBank (accession no.
AF164967). We have also sequenced the F and H genes
of the OP-CDV strain used in our laboratory and found
these sequences to be identical to those of the large plaque
forming variant of OP-CDV (von Messling et al., 2001).
The comparison of the F and H proteins between OP-CDV
and A75/17-V revealed 58 and 55 amino acid differences,
respectively (Table 1).
The efficacy of the F and H protein from wild-type
(FWT/HWT) and OP-CDV (FOP/HOP) to induce cell-to-cell
fusion was next examined. To this end, expression
plasmids encoding the F and H proteins from the two
strains were used in transfection studies in Vero cells and
their activity was determined in a quantitative fusion assay
(Nussbaum et al., 1994). Within 24 h, large syncytia wereobserved in Vero cells cotransfected with plasmids pCI-
FOP and pCI-HOP (Fig. 2A) and the fusion activity was set
at 100% in the quantitative fusion assay (Fig. 2B). Fusion
activities obtained after transfection of only pCI-HWT or
pCI-HOP were considered background levels. In cells
transfected with the wild-type genes (pCI-FWT and pCI-
HWT), no fusion activity was observed (Figs. 2A, B).
When pCI-FOP and pCI-HWT were coexpressed, the fusion
activity barely exceeded the background value after 24 h
of transfection (Figs. 2A, B). However, 2–3 days post-
transfection, few syncytia could be detected in the cell
monolayer (data not shown). Thus, these results are
consistent with the previously described findings demon-
strating that the CDV H protein is a major determinant of
the cell-to-cell fusion activity in Vero cells (von Messling
et al., 2001). Surprisingly, when Vero cells were cotrans-
fected with pCI-FWT and pCI-HOP, only few and small
Table 1
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Pre: signal peptide.
F0: precursor of F1 and F2 subunits.
a A75/17 and A75/17-V CDV share identical F and H proteins.
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Fig. 2. The wild-type F protein reduces syncytium formation in a transient fusion assay. Representative fields of view of Vero (A) and Vero-dogSLAMtag cells
(C) 24 h after transfection with different combinations of wild-type and OP-CDV F and H proteins. Quantitative fusion assays in Vero (B) and Vero-
dogSLAMtag cells (D). One population of Vero and Vero-dogSLAMtag cells were infected with MVA-T7 (MOI, 1). Another population of Vero cells was
transfected with different combinations of F and H proteins, and a plasmid containing the CAT reporter gene under the control of the T7 promoter. Transfected
cells were further incubated in the presence of fusion-inhibiting antibodies (see Materials and methods). At 16 h after incubation at 37 -C, transfected cells were
washed and overlaid onto MVA-T7 infected cells. Mixed cell populations were further incubated at 37 -C for 6 h and fusion was quantified by measuring the
amount of CAT produced. For each experiment, the value measured for the FOP/HOP combination was set to 100%. Means and standard deviations for three
independent experiments in duplicate are shown, *P <0.05.
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fusion assay showing a reduction of about 80% of fusion
activity (Figs. 2A, B).
In order to study the involvement of the canine SLAM
receptor in the fusion process, combinations of the wild-type
and OP-CDV F and H proteins were expressed in Vero-
dogSLAMtag cells. In the presence of SLAM, all homotypic
and heterotypic combinations of F and H proteins were
fusogenic, demonstrating that the cell surface receptor itself
is a contributing determinant of cell-to-cell fusion (Fig. 2C).
These results suggest that lack of fusogenicity of certain F/H
combinations in Vero cells is probably due to the absence of
SLAM, rather than impaired F/H interactions or inefficient
cell surface targeting. In addition, the quantitative fusion
assay confirmed that the wild-type F protein is less
fusogenic than the OP-CDV F protein, also in the presence
of SLAM (Fig. 2D). Taken together, these results showed
that the HWT protein modulates fusogenicity in a receptor-
dependent manner, whereas the FWT protein reduces cell-to-
cell fusion independently of the cell surface receptor.Recovery and characterization of recombinant CDVs with
swapped F and H proteins
Despite the screening of a large number of cell lines, we
were unable to find one in which A75/17-V formed syncytia,
precluding the isolation of recombinant viruses. However,
although only to a limited extent, A75/17-V induced a CPE
in our newly established Vero-dogSLAMtag cells. Using this
cell line, we were able to rescue a persistent A75/17-V from
cDNA. A schematic representation of the genome of the
recombinant virus is shown in Fig. 3A. We next demon-
strated that rA75/17-V grew similarly (Fig. 3B) and
exhibited an identical persistent phenotype of infection
(Fig. 3C) in Vero cells as compared to the parental A75/
17-V virus.
To confirm that the CDV wild-type F protein modulates
fusogenicity, recombinant viruses bearing heterologous
glycoproteins were generated. To facilitate the construction
of recombinant viruses differing in the F and H glycopro-
teins, restriction sites previously introduced in the full-
Fig. 3. Characterization of recombinant CDV viruses. (A) Schematic representation of the genomes of A75/17-V and rA75/17-V. Restriction sites and their
positions that were engineered in the cDNA of rA75/17-V are shown. (B) Growth kinetics of parental A75/17-V (>) and rA75/17-V (n). Vero cells were
infected at an MOI of 0.01. At the indicated hours post-infection, cells were lysed and cell-associated virus was titrated on Vero cells. (C) Immunofluorescence
of Vero cells infected with the parental A75/17-Vand the recombinant rA75/17-V viruses. Cells were stained 2 days post-infection with an anti-CDV N protein
monoclonal antibody followed by a FITC-conjugated anti-mouse IgG. (D) Schematic representation of the genomes of OP-CDV (black boxes) and rA75/17-V
(white boxes). The genomes of the chimeric recombinant viruses are also represented.
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The H gene of A75/17-V was exchanged with that of OP-
CDV, resulting in plasmid pA75/17-V-HOP. The F gene of
both pA75/17-V3 and pA75/17-V-HOP was then replaced by
the FOP gene, resulting in plasmids pA75/17-V-FOP and
pA75/17-V-FOP/HOP. Recombinant viruses were then gen-
erated as described previously (Plattet et al., 2004) with
minor modifications (see Materials and methods). The
various rCDVs were designated as illustrated in Fig. 3D.
In all viruses, the entire F and H genes were sequenced and
no mutations were observed when compared to the trans-
fected plasmids, thus confirming the genetic background of
all chimeric viruses (data not shown).
Fusogenicity of recombinant viruses
We next examined the fusion efficiency and the spread of
the recombinant viruses and of OP-CDV in Vero cells. OP-
CDV induced large syncytia already 24 h post-infection
(hpi) (Fig. 4A). In contrast, rA75/17-V produced a persistent
infection (Fig. 4C). These different phenotypes were also
seen by immunofluorescence analysis (Figs. 4B, D). Threedays after infection, OP-CDV induced extensive CPE
leading to cell death (data not shown), while rA75/17-V
continued to spread within the cell monolayer without
obvious syncytium formation (Fig. 4E). Infection with the
chimeric viruses rA75/17-V-FOP and rA75/17-V-HOP was
characterized by a very limited CPE at 24 hpi, as
demonstrated both by phase contrast microscopy and
immunofluorescence staining (Figs. 4F, G, I, J). At 72 hpi,
immunofluorescence analysis revealed that more than 80%
of the cells were infected but no obvious cell-to-cell fusion
occurred, confirming that the chimeric viruses replicated
and spread efficiently in Vero cells (Figs. 4H, K). When
both F and H proteins of OP-CDV were introduced into the
persistent virus (rA75/17-V-FOP/HOP), cell-to-cell fusion
was highly efficient and the CPE was similar to the parental
OP-CDV (Figs. 4L, M). Thus, in the A75/17-V genetic
background, the presence of either FOP or HOP is not
sufficient to yield efficient cell-to-cell fusion as seen in OP-
CDV infection. Indeed, in order to achieve the fusogenicity
of OP-CDV, both FOP and HOP glycoproteins are needed in
the A75/17-V genome. These results thus showed that the
wild-type CDV F and H proteins are implicated in persistent
Fig. 4. Fusion efficiency and dissemination of recombinant CDV viruses and OP-CDV in Vero cells. Vero cells were infected with a MOI of 0.01 with OP-CDV
(A, B) and rCDVs (C–M). Vero cells were observed after 24 h of infection by phase contrast microscopy (A, C, F, I, L) or stained with anti-CDV N protein
MAb, followed by FITC-conjugated-labeled anti-mouse IgG (B, D, E, G, H, J, K, M). Representative fields of view are shown. Uninfected cell treated in the
same way did not show any fluorescence. N.D., not determined due to extensive CPE.
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to-cell fusion.
The phenotype of the recombinant CDV viruses and OP-
CDV were next examined in Vero-dogSLAMtag cells.
Interestingly, in the presence of the receptor SLAM, all
viruses gained the ability to induce cell-to-cell fusion,
although their fusion-inducing capabilities varied. Indeed,
OP-CDV and rA75/17-V-FOP/HOP produced a very pro-
nounced CPE at 24 hpi (Figs. 5A, B, O, P), whereas rA75/
17-Vand rA75/17-V-HOP-infected cells only exhibited small
and rare syncytia at this time point (Figs. 5C, E, K, M). Two
days post-infection, the latter recombinant viruses produced
a more pronounced CPE characterized by intermediate
syncytia formation (Figs. 5D, F, L, N). Surprisingly, 24 hpost-infection, rA75/17-V-FOP already induced efficient
syncytia formation. However, the syncytia were smaller in
size as compared to OP-CDV and rA75/17-V-FOP/HOP (Fig.
5G, H, I, J). Taken together, these results show that
recombinant viruses bearing the wild-type F protein produce
a more limited CPE and that cellular surface proteins, such
as demonstrated here for SLAM, play a crucial role in
modulating the level of viral cell-to-cell fusion.
SLAM does not significantly influence virus grow kinetics
Since we clearly showed that the canine SLAM molecule
acts as a host cell factor favoring cell-to-cell fusion, we
wondered if virus production was also affected by the
Fig. 5. Fusion efficiency and dissemination of recombinant CDV viruses and OP-CDV in Vero-dogSLAMtag cells. Vero-dogSLAMtag cells were infected with
a MOI of 0.01 with OP-CDV (A, B) and rCDVs (C–P). Vero-dogSLAMtag cells were observed after 24 h and 48 h of infection by phase contrast microscopy
(A, C, D, G, H, K, L, O) or stained with anti-CDV N protein MAb, followed by FITC-conjugated-labelled anti-mouse IgG (B, E, F, I, J, M, N, P).
Representative fields of view are shown. Uninfected cell treated in the same way did not show any fluorescence. N.D., not determined due to extensive CPE.
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all viruses, SLAM did not significantly alter the growth
kinetics (Fig. 6A). However, viruses inducing limited CPE
(rA75/17-V, rA75/17-V FOP, rA75/17-V HOP) showed a
marked delay in virus production, which was independent of
the presence of SLAM.
Efficiency of OP-CDV and rCDVs cell entry in the presence
or absence of SLAM
To assess precisely the entry efficiency of the various
viruses in the presence of SLAM, Vero and Vero-dogSLAM
tag cells were infected with an MOI of 0.01 of the differentviruses titrated in Vero cells. One day post-infection,
immunohistochemistry was performed and stained cells in a
defined area were counted. The number of infected Vero cells
was arbitrary set to 100% for each virus (Fig. 6B). Whereas
viruses bearing the OP-CDV H protein did not show any
significant differences in cell entry efficiency between the
two cell lines, viruses bearing the wild-type H protein clearly
entered Vero cells expressing the canine SLAM receptor 6 to
10 times more efficiently than Vero cells. Thus, cell entry
efficiency is mainly determined by the origin of the H protein.
This result clearly show that virus–cell fusion and cell-to-cell
fusion are closely related but different processes, since cell-
to-cell fusion is regulated by both viral surface glycoproteins.
Fig. 6. (A) Growth kinetics of recombinant CDV viruses in the presence or absence of SLAM. Vero (g) and Vero-dogSLAMtag cells (q) were infected at an
MOI of 0.01 with OP-CDV and the indicated rCDVs. Virus titers were determined at the indicated times post-infection by immunocytochemistry. White
symbols represent the cell-associated virus and black symbols represent infectious progeny released into the cell culture medium. (B) Cell entry efficiency
through different cell surface receptor. Vero (black histogram) and Vero-dogSLAMtag (grey histogram) cells were infected at an MOI of 0.01 with the indicated
CDVs. 24 h post-infection, cells were fixed and stained by immunocytochemistry. Infected cells were counted in 5 separate defined areas of 2 infected cell
cultures. The number of infected Vero cells was arbitrarily set at 100%. Mean values of infected cells T the standard errors of the means from two experiments
are shown.
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infected with viruses producing a persistent infection
To investigate whether persistent infections correlate
with impaired surface glycoproteins targeting, Vero cells
were infected with the various CDVs at an MOI of 0.01.
Prior to lysis, the infected cells were biotinylated at 4 -C to
label the surface-exposed proteins. The total amount of F
and H produced was studied by Western blot analysis of cell
extracts (Figs. 7A, TL). Cell surface-exposed F and H
proteins were analyzed by precipitation with agarose-
coupled streptavidin followed by detection of the proteinsby Western blotting (Figs. 7A, SF). As expected, the surface
glycoproteins of the OP-CDV and rA75/17-V-FOP/HOP
viruses with a highly cytolytic phenotype of infection were
readily expressed at the cell surface after 24 h of infection
(Figs. 7A, SF), at a time when these viruses already
exhibited extensive CPE (see Fig. 4). Interestingly, rA75/
17-V, rA75/17-V-HOP and rA75/17-V-FOP also showed
efficient F and H surface targeting (Fig. 7A, SF). The
glycoproteins of these viruses were analyzed at 3 days post-
infection, when most cells were infected (see Fig. 4) but
when very limited CPE was evident. Western blotting was
also performed with a monoclonal anti-P antibody as a
Fig. 7. Cell surface expression of F and H glycoproteins. Total proteins
(TL) were extracted form Vero cells infected either with rCDVs or OP-
CDV, separated by reducing SDS-PAGE and blotted onto nitrocellulose
membranes. To determine cell surface expression of proteins (SF), duplicate
cultures of infected Vero cells were shifted to 4 -C, biotin labeled, lysed,
and immunoprecipitated overnight with streptavidin coupled to sepharose
beads, separated by reducing SDS-PAGE and blotted onto nitrocellulose
membranes. (A) Blots were probed with an anti-F, an anti-H antiserum. (B)
Blots were probed with an anti-P antiserum, serving as a control. The
position of the H, or of the F0 and F1 proteins is indicated at the right.
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total cell extracts but only trace amounts were seen in
Western blots of surface expressed proteins (Fig. 7B). Thus,
the efficient surface expression of both glycoproteins of
persistent viruses suggests an intrinsic defect of the wild-
type F and/or H protein in mediating the fusion process
rather than an impaired cell surface targeting.Discussion
Functional F and H/HN interactions are well known to be
important for promoting cell-to-cell fusion in paramyxovi-
ruses (Tanabayashi and Compans, 1996; Tsurudome et al.,
1998; Wild et al., 1994). For measles virus (MV), this
interaction has been shown to occur already in the
endoplasmic reticulum (Plemper et al., 2001). Furthermore,host cell molecules promoting or hindering viral–cell fusion
or cell-to-cell fusion have been described for Sendai virus
and Newcastle disease virus (Kumar et al., 1997; Okamoto
et al., 1997). Thus, the fusion process seems to be very
complex and not exclusively dependent on viral determi-
nants, but also on the interaction between viral proteins and
cellular factors. The current model of the paramyxovirus
fusion mechanism proposes that after receptor binding, the
H protein undergoes conformational changes, which also
lead to changes in the tridimensional structure of the F
protein, resulting in the insertion of the hydrophobic fusion
peptide into the cell membrane and finally in membrane
merging (Lamb, 1993; Lamb and Kolakofsky, 2001).
Our results obtained in the transient expression and
infection experiments showed that in the absence of
SLAM, the H protein plays an important role in
fusogenicity, which is consistent with a previous study
(von Messling et al., 2001). Indeed, whereas combinations
involving the wild-type H protein induced very limited
CPE, combinations containing the OP-CDV H protein
produced more pronounced cell-to-cell fusion. While the
precise mechanism by which interaction between the H
protein and the cell surface receptor induces conforma-
tional changes is still unclear, it is tempting to speculate
that the strength of the interaction is crucial for triggering
H protein conformational changes. In this context, we
showed that recombinant viruses containing the wild-type
H protein entered Vero cells expressing SLAM 6–10 times
more efficiently than Vero cells. This suggests that the
wild-type H protein binds to a yet unknown Vero cell
receptor with a reduced affinity compared to the OP-CDV
H protein. As a result of this low binding affinity, cell-to-
cell fusion will be impaired due to a defect of HWT in
supporting the fusion process. In contrast, our results
obtained in Vero-dogSLAMtag cells suggest that both HWT
and HOP can bind to SLAM with sufficiently high affinity
to trigger fusion. This shows that both the H protein and
the cell surface receptor affect cell-to-cell fusion, suggest-
ing that the affinity of the H protein for its receptor is an
important determinant of fusogenicity.
Surprisingly, our transfection and infection experiments
clearly showed that the wild-type F protein also reduced
syncytia formation. In a previous study, von Messling et al.
(2001) demonstrated that fusogenicity was determined
exclusively by the H protein. The apparent discrepancy
between our work and the latter study may be due to the
different origin of the F protein used. Indeed, von Messling
et al. (2001) worked with F proteins obtained from cell
culture-adapted CDV strains, which may be significantly
different in their amino acid sequence with respect to the
original wild-type protein. The F protein of the Vero cell-
adapted virus used in our study is identical to that of the
virulent dog isolate A75/17 (Plattet et al., 2004).
We clearly demonstrated that independently of the
phenotype of infection, both F and H proteins were
efficiently expressed at the cell surface. This strongly
P. Plattet et al. / Virology 337 (2005) 312–326322suggests that the wild-type fusion protein is intrinsically
poorly fusogenic and plays a key role in determining
persistent infection. It has been shown that paramyxovirus
fusion proteins can control fusion efficiency by different
means. Indeed, mutations in the cytoplasmic tail, the signal
peptide, and the F1/F2 subunits have been demonstrated to
affect various steps in the fusion process (Cathomen et al.,
1998b; Dutch and Lamb, 2001; Eichler et al., 2003; Moll et
al., 2002; Seth et al., 2003, 2004; Tong et al., 2002; von
Messling and Cattaneo, 2002; Waning et al., 2004). In
addition, N-linked glycans, as well as lateral interactions
with the attachment protein, have also been demonstrated to
modulate fusogenicity (Corey et al., 2003; Gravel and
Morrison, 2003; Ohuchi et al., 1997; Plemper et al., 2002;
Takimoto et al., 2002; von Messling and Cattaneo, 2003). In
our case, the precise mechanism by which the wild-type F
protein induces a limited CPE is yet unknown. Nevertheless,
while FWT and FOP proteins share identical potential N-
glycosylation sites, it is interesting to note that both proteins
present about 9% differences in their predicted amino acid
sequence. Interestingly, most of these amino acid differ-
ences (71%) are located in the first 135 aa, which has been
designated the pre sequence, whereas only 29% reside in the
precursor F0. Shortening of the pre sequence was shown to
increase fusogenicity (von Messling and Cattaneo, 2002).
Thus, this hyper variable region between FWT and FOP could
be involved in limiting the wild-type F protein-induced
CPE. On the other hand, the fusion-support function of the
H protein could be affected by impaired lateral interactions
when combined with the wild-type F protein, which would
in turn induce a persistent infection. Works is in progress in
order to dissect the precise mechanism by which the F
protein of the neurovirulent CDV strain reduces cell-to-cell
fusion. Taken together, our fusion experiments obtained in
the presence or absence of SLAM suggest that the H/
receptor affinity is the key determinant of cell-to-cell fusion,
the extent of which is modulated by the nature of the F
protein.
In Vero cells, all rCDVs grew to similar titers, although
their growth kinetics appeared to be dependent on the levels
of CPE produced. Viruses producing a very limited CPE
(r-A75/17-V, r-A75/17-V-FOP and r-A75/17-V-HOP) were
characterized by a delay of infectious virus production,
typically attaining a plateau only after 3–5 days post-
infection. In contrast, viruses inducing a marked CPE (r-A75/
17-V-FOP/HOP and OP-CDV) reached a maximum titer
already at 36 h post-infection. As these viruses, except OP-
CDV, differ only in their glycoprotein complexes, this
suggests that the rate of virus release is directly correlated
with the ability of a given virus to induce membrane fusion.
On the other hand, cytolytic viruses spread through a cell
culture both by producing infectious particles and by lateral
cell-to-cell fusion. Thus, the delay of infectious virus
production could simply reflect a slower spread of less
fusogenic viruses through the cell monolayer by depending
predominantly on secondary infections rather than rapidlateral transmission. Another intriguing observation was the
fact that HWT-expressing viruses, which showed a more
efficient cell entry through the SLAM receptor, were
characterized by only a small increase in the rate of virus
production and yields of infectious virus. This observation
remains unclear and needs further investigation. Never-
theless, it is possible that a step in the viral life cycle is
modulated by the presence of SLAM, which in turn leads to a
decrease in virus release.
An unexpected result was the limited CPE induced by
rA75/17-V and rA75/17-V-HOP in Vero-dogSLAMtag
cells. This is in contrast to the transfection experiments,
where expression of the same glycoproteins complexes in
the presence of SLAM showed efficient cell-to-cell fusion.
The most likely explanation for this difference is that in a
virus infection, the M protein is present, which may limit
the rA75/17-V- and rA75/17-V-HOP-induced CPE. Indeed,
it has been shown for MV that the M protein reduces
cell-to-cell fusion by interacting with the cytoplasmic tails
of the F and H proteins (Cathomen et al., 1998a, 1998b).
On the other hand, despite the fact that rA75/17-V-FOP
and rA75/17-V-FOP/HOP harbor the same M gene, they
induce syncytia formation. This could be explained by the
fact that the two latter viruses express the highly
fusogenic OP-CDV F protein. Moreover, as FOP exhibits
three amino acid differences in the cytoplasmic tail (CT)
as compared to FWT, and since the CT domain has been
shown to regulate the fusion process (Bagai and Lamb,
1996; Caballero et al., 1998; Moll et al., 2002; Seth et al.,
2003, 2004; Tong et al., 2002; Waning et al., 2004), one
could speculate that the M/FOP interaction is weaker than
the M/FWT interaction, thus allowing the intrinsic F/H-
induced fusion efficiency to occur. Since the role of M in
cell-to-cell fusion cannot be evaluated in transfection
experiments (Plemper et al., 2002, our unpublished
observations), recombinant CDVs with swapped M
proteins are currently being generated.
We believe that persistence in cultured cells is based on
similar mechanisms as persistence in animals. It is well
known that wild-type CDV produces a persistent infection
in the central nervous system (CNS). In contrast, in
lymphoid organs, CDV infection is highly cytopathic,
which corresponds to our results obtained in Vero and
Vero-dogSLAMtag cells. Thus, it is reasonable to speculate
that (i) the presence or absence of SLAM may also
determine cytolytic versus persistent infection in vivo and
(ii) a yet unidentified low-binding affinity CDV receptor
could be present in the CNS of dogs. To test the first
hypothesis, we are currently performing co-localization
studies of SLAM and viral proteins in tissues of CDV
infected dogs. Taken together, our studies performed with
the A75/17-V virus, which is closely related to the
neurovirulent A75/17 isolate, emphasize the importance
of using viruses with limited cell culture adaptation to
better understand the molecular basis of persistent infection
in CDV.
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Cell culture, virus and infection
Vero cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) (Sigma) containing 10% fetal
bovine serum, penicillin and streptomycin (Gibco) at 37 -C
and 5% CO2. Vero-dogSLAMtag cells (see below) and Bsr-
T7 cells stably expressing the phage T7 RNA polymerase
(Buchholz et al., 1999) were maintained in DMEM
containing 5% fetal bovine serum, penicillin and strepto-
mycin at 37 -C and 5% CO2 in the presence of 0.5 mg/ml
and 1 mg/ml, respectively, of G418 (Sigma).
The A75/17-V strain (A75/17-V) was obtained after 17
blind passages of wild-type virus in Vero cells (Hamburger
et al., 1991). The tissue culture-adapted OP-CDV strain
(gift of U. Kihm, Federal Institute of Virus Diseases and
Immune Prophylaxis, Switzerland) was propagated in Vero
cells.
Cells were infected with the different viruses at the
MOI indicated in the figure legends. After incubation at
37 -C for 2 h, the virus suspension was removed and the
cells were washed with PBS. DMEM supplemented with
10% FCS was then added and the cells were again
incubated at 37 -C.
Generation of a Vero cell line stably expressing the canine
SLAM receptor
For the establishment of the Vero-dogSLAMtag cell line,
the membrane-bound form of canine SLAM cDNA fused to
the influenza virus HA tag (Tatsuo et al., 2001), a generous
gift of Dr. Yanagi, Kyushu University, Japan, was amplified
by PCR using the Expand High-fidelity system (Roche
Biochemicals) and ligated to the HindIII–XhoI-cleaved
pcDNA-Neo eukaryotic expression vector (Stratagene).
Vero cells were then transfected with the pcDNA-dog-
SLAMtag-Neo construct and selected in the presence of 2
mg/ml of G418. The resistant clones were screened by
immunofluorescence staining using an anti-HA-tag FITC-
conjugated antibody (Santa Cruz Biotechnology, Inc.). The
clone, which expressed the highest level of canine SLAM,
was selected for further experiments.
Construction of plasmids
The chlorenphenicol acetyl transferase (CAT) gene was
cloned into the pTM-1 vector (Moss et al., 1990), in which
the CAT gene is under control of the T7 promoter. The
resulting plasmid was designated pTM-CAT.
The wild-type F and H proteins were cloned into the
eukaryotic expression vector pCI (Promega), as described
elsewhere (Cherpillod et al., 2000). To generate plasmids
expressing the OP-CDV glycoproteins, RNA was extracted
from OP-CDV-infected Vero cells using the RNeasy kit
(Qiagen). Regions spanning the F and H genes were thenreverse transcribed from viral genomic RNA using Super-
script III (Qiagen) reverse transcriptase (RT) and gene-
specific primers. PCR amplification was performed using
the Expand High-fidelity system (Roche Biochemicals) with
specific primers and cloned into the eukaryotic expression
vector using standard methods. As already stipulated in
Introduction, wild-type A75/17 and A75/17-V present
identical F and H proteins and are termed in this study
FWT and HWT, respectively.
Plasmid pA75/17-V3, carrying the full-length cDNA
genome of A75/17-V, has been described previously (Plattet
et al., 2004). To exchange the F and H genes of pA75/17-V3
with those of OP-CDV, the FOP and HOP genes were
amplified from the eukaryotic expression plasmids pCI-FOP
and pCI-HOP (see below), and subcloned into pGEM-Teasy
(Promega). The PCR primers contained the transcription
regulatory elements (EIS) of A75/17-V and the restriction
sites BstEII and MluI (FOP) or MluI and BssHII (HOP). The
fragment containing the HOP gene was then excised from
pGEM-T easy construct and ligated to MluI–BssHII-
cleaved pA75/17-V3, resulting in plasmid pA75/17-V-HOP.
The fragment containing the FOP gene was excised from
pGEM-T easy vector and ligated into pA75/17-V3 and
pA75/17-V-HOP, resulting in plasmids pA75/17-V-FOP and
pA75/17-V-FOP/HOP, respectively.
Transfections and quantitative fusion assay
Vero and Vero-dogSLAMtag cells, in 6-well plates at
90% confluency, were cotransfected with 2 Ag of pCI-FOP,
pCI-HOP, pCI-FWT and pCI-HWT in different combinations,
using Lipofectamine 2000 (Gibco) according to the manu-
facturer’s protocol. Pictures of transfected cells were taken
24 h after transfection with a microscope equipped with a
DC 350FX digital camera (Leica).
The quantitative fusion assay was performed essentially
as described previously (Nussbaum et al., 1994). For
measles virus, the fusion inhibitory peptide (FIP) has been
used to inhibit F/H-induced syncytia formation during the
first period of incubation (Plemper et al., 2003). As the
FIP did not have the desired effect in transfection
experiments using the CDV F gene, Vero cells cotrans-
fected with the F and H expression plasmids and 0.1 Ag
of pTM-CAT were incubated in the presence of a canine
distemper antiserum (VMRD, Inc.) and a rabbit polyclonal
anti-CD9 antiserum (Santa Cruz Biotechnology, Inc.). In
parallel, separate 6-well plates of Vero or Vero-dog-
SLAMtag cells at 30% confluency were infected with the
recombinant vaccinia virus MVA-T7 expressing the T7
RNA polymerase (Sutter et al., 1995) at a multiplicity of
infection (MOI) of 1. Sixteen hours post-transfection or
post-infection, transfected Vero cells were subcultured in
duplicate with the MVA-T7-infected Vero or Vero-dog-
SLAMtag cells. After incubation at 37 -C for 6 h, cells
were lysed, and the CAT production was determined
using an ELISA kit (Roche Biochemicals).
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Recombinant viruses were recovered using Bsr-T7 cells
as described (Plattet et al., 2004). Briefly, Bsr-T7 cells were
transfected with N, P and L expression vectors together with
a DNA copy of the relevant CDV genome. Cells transfected
with either pA75/17-V-FOP or pA75/17-V3 were overlaid on
Vero-dogSLAMtag cells, whereas cells transfected with
either pA75/17-V-FOP/HOP or pA75/17-V-HOP were over-
laid on Vero cells. For each virus, four syncytia were
isolated and incubated with fresh Vero cells in 6-well plates.
The infected cells were expanded in 10-cm dishes. When
severe cytopathic effect was observed or after 5 days, the
culture medium was replaced by 2 ml of Opti-MEM (Gibco)
and the cells were harvested and lysed by freeze–thaw. The
cleared supernatants were used for further analysis. To
verify the identity of recombinant viruses, total RNA was
isolated from infected cells using RNeasy-kit (Qiagen),
reverse transcribed and subjected to PCR amplification, as
described previously (Plattet et al., 2004). The resulting
PCR fragments were sequenced using an ABI Prism 3100
automated sequencer (Applied Biosystems). For all viruses,
the titer was determined by limiting dilution of the viral
stock followed by immunohistochemical staining using a
CDV-N-specific monoclonal D110 antibody, as described
previously (Bollo et al., 1986).
Western blotting
Proteins were separated by electrophoresis in a 10%
reducing SDS-polyacrylamide gel and blotted onto nitro-
cellulose transfermembranes (Schleicher and Schuell). The
membranes were incubated with a rabbit anti-F or an anti-H
antiserum (Cherpillod et al., 1999) or an anti-P-specific
monoclonal antibody (Martens et al., 1995). After incuba-
tion with peroxidase-conjugated goat anti-rabbit immuno-
globulin G (DakoCytomation) or goat anti-mouse
immunoglobulin G (Cell Signaling) for 45 min at room
temperature, proteins were visualized by enhanced chem-
iluminescence (Amersham Biosciences).
Surface biotinylation
Biotinylation was performed with a biotinylation kit
(Roche) according to the instructions of the manufacturer.
Briefly, cells were infected with the various viruses at an
MOI of 0.01 for 1 or 3 days, depending on their phenotype
of infection. After a wash in cold PBS, cells were
incubated in biotinylation buffer containing 0.05 mg/ml
of biotin-7-NHS for 15 min at 4 -C. The reaction was
terminated by adding 50 Al/ml of stop solution to yield a
final concentration of 50 mM NH4Cl and incubated for 15
min at room temperature. Cells were washed with PBS,
and scraped into lysis buffer containing protease inhibitors.
The lysates were cleared by centrifugation at 20 000g
for 15 min at 4 -C. One hundred and fifty micrograms ofbiotinylated proteins were absorbed overnight to Immuno-
pure immobilized streptavidin–agarose beads (Pierce) at 4
-C. Beads were pelleted by centrifugation at 8000 rpm for
30 s in a microfuge and washed three times with lysis
buffer before 25 Al of 2 loading buffer containing 100
mM DTT was added. Western blot analysis using rabbit
anti-F or anti-H antiserum, or an anti-P monoclonal
antibody was performed as described above. To determine
the total amount of H, F or P protein present in infected
cells, 15 Ag of total proteins of infected cells were used for
Western blotting.
Indirect immunofluorescence assay
Vero and Vero-dogSLAMtag cells at 80% confluency
were infected at an MOI of 0.01 for 2 h at 37 -C with the
respective viruses. One day after infection (or as specified in
the manuscript), the cells were fixed with 5% acetic acid:
95% ethanol (v/v), blocked with 5% goat serum and stained
with the CDV-N-specific monoclonal antibody D110. Cells
were then incubated with fluorescein isocyanate-conjugated
goat anti-mouse immunoglobulin G (Sigma) and examined
by fluorescence microscopy.Acknowledgments
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